Paper3350834
Cimetidine enhances cisplatin toxicity in mice.
Dorr RT and 1 other. J Cancer Res Clin Oncol, 1988. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Cimetidine enhances cisplatin toxicity in mice. Papers, record 3350834. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3350834
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cimetidine | Major topic |
| Cisplatin | Major topic |
| Animals | |
| Drug Synergism | |
| Male | |
| Mice | |
| Mice, Inbred DBA |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 657722 | Effect of cimetidine on renal function in normal man. | Clin Pharmacol Ther | 1978 | https://conductscience.org/library/papers/657722 | PubMed |
| 2 | 3948164 | Interaction of cimetidine but not ranitidine with cyclophosphamide in mice. | Cancer Res | 1986 | https://conductscience.org/library/papers/3948164 | PubMed |
| 3 | 3729972 | The nature of microsomal monooxygenase inhibition by cimetidine. | Biochem Pharmacol | 1986 | https://conductscience.org/library/papers/3729972 | PubMed |
| 4 | 6751184 | Cimetidine. I. Developments, pharmacology, and efficacy. | Ann Intern Med | 1982 | https://conductscience.org/library/papers/6751184 | PubMed |
| 5 | 7059463 | Cimetidine enhancement of cyclophosphamide antitumour activity. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7059463 | PubMed |
| 6 | 6788056 | Effect of cimetidine on renal function in man. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6788056 | PubMed |
| 7 | 14341275 | A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. | Biometrika | 1965 | https://conductscience.org/library/papers/14341275 | PubMed |
| 8 | 7059066 | Cimetidine-induced acute renal failure. | Ann Intern Med | 1982 | https://conductscience.org/library/papers/7059066 | PubMed |
| 9 | 4957125 | Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. | Cancer Chemother Rep | 1966 | https://conductscience.org/library/papers/4957125 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30191328 | Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity. | Pharm Res | 2018 | https://conductscience.org/library/papers/30191328 | PubMed |
| 29037232 | A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice. | BMC Cancer | 2017 | https://conductscience.org/library/papers/29037232 | PubMed |
| 8261581 | WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8261581 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3350834
GET https://conductscience.org/api/papers/v1/3350834/authors